or Try an Advanced Search...

    Uveitis Stocks List

    Symbol Grade Name % Change
    ALDX D Aldeyra Therapeutics, Inc. -3.19
    XOMA C XOMA Corporation -2.11
    SLRN F Acelyrin Inc. 1.88
    OKYO D OKYO Pharma Limited 2.03
    CANF F Can-Fite Biopharma Ltd Sponsored ADR (Israel) 6.03
    CLSD D Clearside Biomedical, Inc. 6.30
    EYPT F EyePoint Pharmaceuticals, Inc. 9.60
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Medicine Biotechnology Immunology Inflammatory Biopharmaceutical Clinical Medicine Eye Eye Diseases Macular Degeneration Macular Edema Monoclonal Antibodies Non Infectious Uveitis Wet Age Related Macular Degeneration Acne Adverum Biotechnologies Allergic Conjunctivitis Allergy Antibodies Antibody Antibody Product

    Related ETFs - A few ETFs which own one or more of the above listed Uveitis stocks.

    Symbol Grade Name Weight
    XPH D SPDR S&P Pharmaceuticals ETF 2.05
    PBE C PowerShares Dynamic Biotech & Genome 1.97
    PILL D Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 1.64
    BTEC D Principal Healthcare Innovators Index ETF 0.32
    IWC C iShares Microcap ETF 0.29
    View all Uveitis ETFs...
    Compare ETFs
    Compare PBE to PILL Compare XPH to BTEC Compare XPH to PBE

        Uveitis Stocks Recent News

        Date Stock Title
        May 9 CLSD Clearside Biomedical GAAP EPS of -$0.17 misses by $0.03, revenue of $0.23M misses by $0.45M
        May 9 CLSD Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate Update
        May 9 CANF Can-Fite stock up on FDA IND clearance for namodenoson to treat MASH patients in mid-stage study
        May 9 SLRN Acelyrin names Mina Kim as new Chief Executive Officer
        May 9 SLRN ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones
        May 9 SLRN ACELYRIN, INC. Announces Leadership Transition
        May 9 XOMA XOMA GAAP EPS of -$0.86, revenue of $1.49M
        May 9 XOMA XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
        May 9 CANF Can-Fite: FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study
        May 8 CLSD Clearside Biomedical Q1 2024 Earnings Preview
        May 8 CLSD Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences Conference
        May 8 EYPT EyePoint Pharmaceuticals GAAP EPS of -$0.55 misses by $0.17, revenue of $11.68M beats by $2.54M
        May 8 ALDX Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease
        May 8 OKYO OKYO Pharma Announces Participation in May 2024 Investor Conferences
        May 8 EYPT EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
        May 8 EYPT Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
        May 7 XOMA Certara, Inc. (CERT) Q1 Earnings Meet Estimates
        May 7 EYPT EyePoint Stock: NPDR Endpoint Miss Is A Buying Opportunity Based On Lead Program
        May 7 XOMA Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
        May 6 EYPT EyePoint's Setback In NPDR Does Not Bode Well For DME (Rating Downgrade)
        Related Industries: Biotechnology
        Related Stock Lists: Medicine Biotechnology Immunology Inflammatory Biopharmaceutical Clinical Medicine Eye Eye Diseases Macular Degeneration Macular Edema Monoclonal Antibodies Non Infectious Uveitis Wet Age Related Macular Degeneration Acne Adverum Biotechnologies Allergic Conjunctivitis Allergy Antibodies Antibody Antibody Product
        Uveitis

        Uveitis is the inflammation of the uvea, the pigmented layer that lies between the inner retina and the outer fibrous layer composed of the sclera and cornea. The uvea consists of the middle layer of pigmented vascular structures of the eye and includes the iris, ciliary body, and choroid. Uveitis is an ophthalmic emergency and requires a thorough examination by an optometrist or ophthalmologist and urgent treatment to control the inflammation. It is often associated with other ocular problems.

        More about Uveitis
        Browse All Tags